Beta Bionics SEC filings
Filter: All · 8-K · 10-Q · 10-K · Form 4
Results of operations and financial condition · Financial statements and exhibits
AI summary, unreviewedBeta Bionics Q3 2026 Net Sales Rise 30% to $35.5 Million, Beating Consensus; Full-Year Revenue Guidance Low End Raised to $124 Million
Other events · Financial statements and exhibits
Regulation FD disclosure · Other events · Financial statements and exhibits
Results of operations and financial condition · Financial statements and exhibits